יום שישי, י״ח תמוז תשפ״וFriday, July 3, 2026
Follow Us
An experimental drug developed at a TAU lab may be suitable for treating a range of rare syndromes that impair brain functions.
The symptoms that were remedied using NAP: slow development, poor communication, brains with a small number of synapses, and low electrical activity.
July 3, 2026 
